CALHOUN, Ga., July 16, 2024 (GLOBE NEWSWIRE) -- Mohawk Industries, Inc. (NYSE: MHK) today published its 15th annual impact report, Surfaces with Purpose, which documents the Company’s 2023 progres......
Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its poten......
ZURICH, Switzerland, July 16, 2024 (GLOBE NEWSWIRE) -- The Swiss-based humanitarian non-profit organisation, Andan Foundation, in collaboration with MIT Solve of the Massachusetts Institute of Techn......
